The AHA today expressed support for the Opioid Workforce Treatment Act of 2018 (H.R. 5818/S. 2843), bipartisan, bicameral legislation that would reduce the shortage of opioid treatment providers by increasing the number of Medicare-funded residency slots in hospitals with programs focused on substance use disorder treatment. A recent report from the National Academies of Sciences, Engineering and Medicine highlighted the dearth of clinicians with specialized training in Medication Assisted Treatment, and the Substance Abuse and Mental Health Services Administration has estimated that only 10% of the 22 million Americans with a SUD receive treatment. “Your legislation would address these shortages by providing 1,000 additional Medicare-funded residency positions in approved residency programs in addiction medicine, addiction psychiatry or pain management,” AHA said in letters of support to the bills’ sponsors. “These new slots would constitute a major step toward increasing access to SUD treatment for communities in need.”

Related News Articles

Insights and Analysis
In this guest column, Kenneth Kaufman, chair of Kaufman Hall, discusses how hospitals need scale to keep pace in today’s environment, as well as continue to…
Chairperson's File
We look ahead with optimism as we advance the goals of improving health care quality, equity, access and affordability for all Americans.  
Headline
The Federal Trade Commission’s approach to reviewing hospital mergers “is overbroad, does not properly credit the many pro-consumer benefits of hospital…
Headline
The AHA today voiced support for a Centers for Medicare…
Headline
The AHA’s Institute for Diversity and Health Equity today named Duane Elliott Reynolds as its new president and CEO.
Headline
A federal judge in Texas last night ruled that the entire Affordable Care is unconstitutional because Congress repealed the tax penalty enforcing the law's…